Logo image of NTR

NUTRIEN LTD (NTR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NTR - CA67077M1086 - Common Stock

60.995 USD
+1.65 (+2.79%)
Last: 1/13/2026, 10:56:00 AM
Fundamental Rating

5

Taking everything into account, NTR scores 5 out of 10 in our fundamental rating. NTR was compared to 82 industry peers in the Chemicals industry. NTR has a medium profitability rating, but doesn't score so well on its financial health evaluation. NTR is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

NTR had positive earnings in the past year.
NTR had a positive operating cash flow in the past year.
NTR had positive earnings in each of the past 5 years.
In the past 5 years NTR always reported a positive cash flow from operatings.
NTR Yearly Net Income VS EBIT VS OCF VS FCFNTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

NTR has a better Return On Assets (3.49%) than 70.73% of its industry peers.
Looking at the Return On Equity, with a value of 7.20%, NTR is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
NTR has a Return On Invested Capital (4.86%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for NTR is above the industry average of 6.10%.
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROIC 4.86%
ROA(3y)5.91%
ROA(5y)5%
ROE(3y)12.48%
ROE(5y)10.56%
ROIC(3y)8.34%
ROIC(5y)7.09%
NTR Yearly ROA, ROE, ROICNTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 6.79%, NTR is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
NTR's Profit Margin has declined in the last couple of years.
NTR's Operating Margin of 12.63% is fine compared to the rest of the industry. NTR outperforms 67.07% of its industry peers.
In the last couple of years the Operating Margin of NTR has grown nicely.
The Gross Margin of NTR (30.20%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NTR has remained more or less at the same level.
Industry RankSector Rank
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
OM growth 3Y-13.46%
OM growth 5Y2.09%
PM growth 3Y-38.9%
PM growth 5Y-12.08%
GM growth 3Y-4.64%
GM growth 5Y1.41%
NTR Yearly Profit, Operating, Gross MarginsNTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NTR is destroying value.
NTR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for NTR has been reduced compared to 5 years ago.
Compared to 1 year ago, NTR has a worse debt to assets ratio.
NTR Yearly Shares OutstandingNTR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
NTR Yearly Total Debt VS Total AssetsNTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

Based on the Altman-Z score of 1.79, we must say that NTR is in the distress zone and has some risk of bankruptcy.
NTR's Altman-Z score of 1.79 is in line compared to the rest of the industry. NTR outperforms 47.56% of its industry peers.
NTR has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as NTR would need 6.46 years to pay back of all of its debts.
NTR's Debt to FCF ratio of 6.46 is fine compared to the rest of the industry. NTR outperforms 74.39% of its industry peers.
NTR has a Debt/Equity ratio of 0.53. This is a neutral value indicating NTR is somewhat dependend on debt financing.
NTR's Debt to Equity ratio of 0.53 is fine compared to the rest of the industry. NTR outperforms 64.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Altman-Z 1.79
ROIC/WACC0.43
WACC11.38%
NTR Yearly LT Debt VS Equity VS FCFNTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

NTR has a Current Ratio of 1.41. This is a normal value and indicates that NTR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.41, NTR is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
A Quick Ratio of 0.89 indicates that NTR may have some problems paying its short term obligations.
NTR's Quick ratio of 0.89 is on the low side compared to the rest of the industry. NTR is outperformed by 68.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.89
NTR Yearly Current Assets VS Current LiabilitesNTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.48% over the past year.
Measured over the past years, NTR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.65% on average per year.
Looking at the last year, NTR shows a small growth in Revenue. The Revenue has grown by 0.25% in the last year.
The Revenue has been growing slightly by 5.28% on average over the past years.
EPS 1Y (TTM)13.48%
EPS 3Y-17.44%
EPS 5Y10.65%
EPS Q2Q%148.72%
Revenue 1Y (TTM)0.25%
Revenue growth 3Y-2.14%
Revenue growth 5Y5.28%
Sales Q2Q%12.78%

3.2 Future

Based on estimates for the next years, NTR will show a small growth in Earnings Per Share. The EPS will grow by 6.03% on average per year.
NTR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.11% yearly.
EPS Next Y35.95%
EPS Next 2Y16.62%
EPS Next 3Y8.72%
EPS Next 5Y6.03%
Revenue Next Year2.75%
Revenue Next 2Y1.95%
Revenue Next 3Y1.14%
Revenue Next 5Y2.11%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NTR Yearly Revenue VS EstimatesNTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B
NTR Yearly EPS VS EstimatesNTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.10, which indicates a correct valuation of NTR.
NTR's Price/Earnings ratio is a bit cheaper when compared to the industry. NTR is cheaper than 70.73% of the companies in the same industry.
NTR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.25.
Based on the Price/Forward Earnings ratio of 12.81, the valuation of NTR can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NTR indicates a somewhat cheap valuation: NTR is cheaper than 75.61% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of NTR to the average of the S&P500 Index (23.98), we can say NTR is valued slightly cheaper.
Industry RankSector Rank
PE 15.1
Fwd PE 12.81
NTR Price Earnings VS Forward Price EarningsNTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NTR is valued cheaply inside the industry as 82.93% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, NTR is valued cheaper than 80.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.44
EV/EBITDA 6.89
NTR Per share dataNTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of NTR may justify a higher PE ratio.
PEG (NY)0.42
PEG (5Y)1.42
EPS Next 2Y16.62%
EPS Next 3Y8.72%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.75%, NTR has a reasonable but not impressive dividend return.
NTR's Dividend Yield is rather good when compared to the industry average which is at 2.34. NTR pays more dividend than 84.15% of the companies in the same industry.
NTR's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 3.75%

5.2 History

The dividend of NTR has a limited annual growth rate of 2.94%.
NTR has been paying a dividend for over 5 years, so it has already some track record.
NTR has decreased its dividend recently.
Dividend Growth(5Y)2.94%
Div Incr Years1
Div Non Decr Years1
NTR Yearly Dividends per shareNTR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

NTR pays out 58.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
NTR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.76%
EPS Next 2Y16.62%
EPS Next 3Y8.72%
NTR Yearly Income VS Free CF VS DividendNTR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
NTR Dividend Payout.NTR Dividend Payout, showing the Payout Ratio.NTR Dividend Payout.PayoutRetained Earnings

NUTRIEN LTD

NYSE:NTR (1/13/2026, 10:56:00 AM)

60.995

+1.65 (+2.79%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners74.04%
Inst Owner Change-0.01%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap29.48B
Revenue(TTM)26.62B
Net Income(TTM)1.81B
Analysts72.59
Price Target49.49 (-18.86%)
Short Float %2.51%
Short Ratio5.1
Dividend
Industry RankSector Rank
Dividend Yield 3.75%
Yearly Dividend2.15
Dividend Growth(5Y)2.94%
DP58.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.24%
Min EPS beat(2)0.97%
Max EPS beat(2)9.5%
EPS beat(4)2
Avg EPS beat(4)-16.43%
Min EPS beat(4)-64.42%
Max EPS beat(4)9.5%
EPS beat(8)4
Avg EPS beat(8)-12.86%
EPS beat(12)4
Avg EPS beat(12)-17.39%
EPS beat(16)6
Avg EPS beat(16)-15.21%
Revenue beat(2)1
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)1.29%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.9%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-3.94%
Revenue beat(12)4
Avg Revenue beat(12)-3.47%
Revenue beat(16)5
Avg Revenue beat(16)-2.55%
PT rev (1m)2.78%
PT rev (3m)2.67%
EPS NQ rev (1m)-1.23%
EPS NQ rev (3m)14.63%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)4.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 15.1
Fwd PE 12.81
P/S 1.11
P/FCF 13.44
P/OCF 7.1
P/B 1.17
P/tB 2.61
EV/EBITDA 6.89
EPS(TTM)4.04
EY6.62%
EPS(NY)4.76
Fwd EY7.8%
FCF(TTM)4.54
FCFY7.44%
OCF(TTM)8.59
OCFY14.09%
SpS55.08
BVpS51.97
TBVpS23.36
PEG (NY)0.42
PEG (5Y)1.42
Graham Number68.73
Profitability
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROCE 8.09%
ROIC 4.86%
ROICexc 4.93%
ROICexgc 7.23%
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
FCFM 8.24%
ROA(3y)5.91%
ROA(5y)5%
ROE(3y)12.48%
ROE(5y)10.56%
ROIC(3y)8.34%
ROIC(5y)7.09%
ROICexc(3y)8.53%
ROICexc(5y)7.25%
ROICexgc(3y)13.18%
ROICexgc(5y)11.36%
ROCE(3y)13.73%
ROCE(5y)11.62%
ROICexgc growth 3Y-18.22%
ROICexgc growth 5Y4.99%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y6.12%
OM growth 3Y-13.46%
OM growth 5Y2.09%
PM growth 3Y-38.9%
PM growth 5Y-12.08%
GM growth 3Y-4.64%
GM growth 5Y1.41%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Debt/EBITDA 2.31
Cap/Depr 81.9%
Cap/Sales 7.36%
Interest Coverage 4.41
Cash Conversion 72.18%
Profit Quality 121.28%
Current Ratio 1.41
Quick Ratio 0.89
Altman-Z 1.79
F-Score8
WACC11.38%
ROIC/WACC0.43
Cap/Depr(3y)112.14%
Cap/Depr(5y)101.14%
Cap/Sales(3y)7.97%
Cap/Sales(5y)7.55%
Profit Quality(3y)156.44%
Profit Quality(5y)184.5%
High Growth Momentum
Growth
EPS 1Y (TTM)13.48%
EPS 3Y-17.44%
EPS 5Y10.65%
EPS Q2Q%148.72%
EPS Next Y35.95%
EPS Next 2Y16.62%
EPS Next 3Y8.72%
EPS Next 5Y6.03%
Revenue 1Y (TTM)0.25%
Revenue growth 3Y-2.14%
Revenue growth 5Y5.28%
Sales Q2Q%12.78%
Revenue Next Year2.75%
Revenue Next 2Y1.95%
Revenue Next 3Y1.14%
Revenue Next 5Y2.11%
EBIT growth 1Y19.73%
EBIT growth 3Y-15.31%
EBIT growth 5Y7.48%
EBIT Next Year100.07%
EBIT Next 3Y24.49%
EBIT Next 5Y14.07%
FCF growth 1Y-22.69%
FCF growth 3Y-13.08%
FCF growth 5Y-4.89%
OCF growth 1Y-26.52%
OCF growth 3Y-3.11%
OCF growth 5Y-0.72%

NUTRIEN LTD / NTR FAQ

What is the ChartMill fundamental rating of NUTRIEN LTD (NTR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NTR.


Can you provide the valuation status for NUTRIEN LTD?

ChartMill assigns a valuation rating of 6 / 10 to NUTRIEN LTD (NTR). This can be considered as Fairly Valued.


How profitable is NUTRIEN LTD (NTR) stock?

NUTRIEN LTD (NTR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for NTR stock?

The Price/Earnings (PE) ratio for NUTRIEN LTD (NTR) is 15.1 and the Price/Book (PB) ratio is 1.17.


What is the financial health of NUTRIEN LTD (NTR) stock?

The financial health rating of NUTRIEN LTD (NTR) is 3 / 10.